EcoDrugPlus

Adenosine A2a Receptor B

Ensembl ID : ENSIPUG00000003063
Gene Symbol: ADORA2AB
3 Cross references
198 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSIPUG00000024117
Gene Symbol: ADORA2B
3 Cross references
200 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSIPUG00000021522
Gene Symbol: ADA
2 Cross references
216 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSIPUG00000025036
Gene Symbol: ADRA1AA
4 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 1ba

Ensembl ID : ENSIPUG00000024067
Gene Symbol: ADRA1BA
3 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 1bb

Ensembl ID : ENSIPUG00000003153
Gene Symbol: ADRA1BB
4 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSIPUG00000015829
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSIPUG00000010606
Gene Symbol: ADRA2A
3 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSIPUG00000004154
Gene Symbol: ADRA2B
1 Cross references
174 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSIPUG00000009930
Gene Symbol: ADRA2C
1 Cross references
160 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSIPUG00000017138
Gene Symbol: ADRB1
3 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2, Surface B

Ensembl ID : ENSIPUG00000010148
Gene Symbol: ADRB2B
4 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).